运用“土郁夺之”理论指导治疗湿热内蕴型溃疡性结肠炎的系统评价

2017-06-01 12:40朱叶珊陈建权刘建平
中国医药导报 2017年10期
关键词:系统评价溃疡性结肠炎

朱叶珊++陈建权++刘建平

[摘要] 目的 觀察运用“土郁夺之”理论指导治疗湿热内蕴型溃疡性结肠炎的临床效果并对其进行可能的机制探讨。 方法 将2015年1月~2016年6月河北省玉田县医院及河北省唐山市中医医院收治的湿热内蕴型溃疡性结肠炎患者74例,将其随机分为治疗组(37例)陈皮、茯苓、栀子、半夏、黄芩、黄柏、连翘、竹茹、阿胶、伏龙肝等)口服治疗,对照组给予美沙拉嗪肠溶片口服和安慰剂口服治疗,两组均以4周为1个疗程。观察两组的临床症状疗效、结肠镜疗效和血清IL-17、IL-23及IL-10的含量。 结果 治疗1个疗程后,治疗组的临床症状疗效、结肠镜疗效的总有效率分别为94.59%和97.30%,对照组分别为81.08%和86.49%,治疗组的临床症状疗效和结肠镜疗效均优于对照组(P < 0.05)。治疗后,两组患者血清IL-17、IL-23含量较治疗前显著降低,差异有统计学意义(P < 0.05),且治疗后,治疗组血清IL-17、IL-23含量显著低于对照组,差异有统计学意义(P < 0.05);治疗后,两组患者血清IL-10含量均显著高于治疗前(P < 0.05),且治疗组治疗后血清IL-10含量高于对照组,差异有统计学意义(P < 0.05)。治疗过程中,两组患者均未出现严重的不良反应。 结论 运用“土郁夺之”理论指导治疗湿热内蕴型溃疡性结肠炎的临床症状效果和结肠镜效果均显著,其作用机制可能与降低血清IL-17、IL-23水平和升高血清IL-10的含量有关,且无不良反应,值得临床推广使用和进行下一步的深入研究。

[关键词] 土郁夺之;湿热内蕴型;溃疡性结肠炎;系统评价

[中图分类号] R574.05 [文献标识码] A [文章编号] 1673-7210(2017)04(a)-0109-04

[Abstract] Objective To observe the clinical effect of "Tuyu Duozhi" in the treatment of ulcerative colitis with damp-heat syndrome and to explore its possible mechanism. Methods Seventy-four patients of ulcerative colitis with damp-heat syndrome were randomly divided into treatment group (37 cases) and control group (37 cases). The patients were treated in Yutian County Hospital and Tangshan Traditional Chinese Medicine Hospital from January 2015 to June 2016. The treatment group was given Mesalazine Enteric-coated Tablets combined with traditional Chinese medicine decoction (using the theory of "Tuyu Duozhi" theory cube Qingzhong Decoction: Coptidis Rhizoma, Citri Reticulatae Pericarpium, Poria, Gardeniae Fructus, Pinelliae Rhizoma, Scutellariae Radix, Phellodendri Chinensis Cortex, Forsythiae Fructus, Bambusae Caulis In Taenias, Asini Corii Colla, Terra Flavausta, etc.) oral treatment, the control group was given Mesalazine Enteric-coated Tablets and placebo oral treatment, two groups were taken 4 weeks as a course of treatment. The clinical symptoms effect, colonoscopy effect, the contents of serum IL-17, IL-23 and IL-10 were observed in the two groups. Results After one course of treatment, the total effective rates of the clinical symptoms effect and colonoscopy effect were 94.59% and 97.30% in the treatment group respectively, which were 81.08% and 86.49% in the control group, the clinical symptoms effect and colonoscopy effect of the treatment group were better than the control group (P < 0.05). After treatment, the serum levels of IL-17 and IL-23 in the two groups were significantly lower than those before treatment (P < 0.05), after treatment, the levels of serum IL-17 and IL-23 in the treatment group were lower than the control group (P < 0.05), after treatment, the levels of serum IL-10 in the two groups were significantly higher than those before treatment (P < 0.05), after treatment, the level of serum IL-10 in the treatment group was higher than that in the control group, the difference was statistically significant (P < 0.05). In the course of treatment, there were no serious adverse reactions in the two groups. Conclusion The clinical symptoms effect and colonoscopy effect of "Tuyu Duozhi" in the treatment of ulcerative colitis with damp-heat syndrome are significant. The mechanism may be related to the decrease of serum IL-17, IL-23 levels and the increase of serum IL-10 levels, with no adverse reactions, it is worthy of clinical use and the next step in-depth study.

猜你喜欢
系统评价溃疡性结肠炎
中药注射剂治疗冠心病的系统评价再评价
高压氧治疗血管性痴呆随机对照试验的Meta分析
研究美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的临床有效性
健康教育在溃疡性结肠炎患者护理中的效果
美沙拉嗪口服联合保留灌肠治疗溃疡性结肠炎的效果
肠炎清对ICUC大鼠结肠组织TLR4、NF—κB蛋白表达、TLR4mRNA的影响
细辛脑注射液治疗慢性阻塞性肺疾病急性加重期疗效的Meta分析
美沙拉嗪联合双歧三联活菌治疗溃疡性结肠炎的临床效果
丹红注射液治疗特发性肺纤维化临床疗效及安全性的Meta分析
银杏叶注射液治疗急性脑梗死随机对照试验的系统评价